AM PHARMA
AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derived peptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
AM PHARMA
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2000-01-01
Address:
Bunnik, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.am-pharma.com
Total Employee:
11+
Status:
Active
Contact:
+ 31 (0)30 228 92 22
Total Funding:
207.54 M EUR
Technology used in webpage:
Google Maps ReCAPTCHA Person Schema Gravatar Profiles Gravity Forms Akismet Akismet Non Hosted Dutch Server Location
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arphio
Arphio is an orphan pharmaceutical company founded on the mission to improve patient access to vital treatments for rare diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
SIDANIS
SIDANIS is a biopharmaceutical company specialized in developing drugs to prevent and treat infectious diseases in human & animal health.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Treamid Therapeutics
Treamid Therapeutics is a pharmaceutical company that new chemical entities for inflammatory respiratory and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Eurazeo
Eurazeo investment in Venture Round - AM Pharma
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Venture Round - AM Pharma
Idinvest Partners
Idinvest Partners investment in Venture Round - AM Pharma
Gilde Healthcare
Gilde Healthcare investment in Venture Round - AM Pharma
Forbion Capital Partners
Forbion Capital Partners investment in Venture Round - AM Pharma
BB Biotech Ventures
BB Biotech Ventures investment in Venture Round - AM Pharma
Ysios Capital
Ysios Capital investment in Venture Round - AM Pharma
European Investment Bank
European Investment Bank investment in Debt Financing - AM Pharma
Andera Partners
Andera Partners investment in Venture Round - AM Pharma
Kurma Partners
Kurma Partners investment in Venture Round - AM Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-15 | AM-Pharma Appoints Lars Boesgaard as Chief Financial Officer and Establishes U.S. Affiliate AM-Pharma Inc. |
Official Site Inspections
http://www.am-pharma.com Semrush global rank: 7 M Semrush visits lastest month: 940
- Host name: ayni.savviihq.com
- IP address: 62.221.215.181
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "AM Pharma"
AM Pharma - Crunchbase Company Profile & Funding
AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It …See details»
AM-Pharma Org Chart + Executive Team - The Official Board
AM-Pharma Org Chart www.am-pharma.com. has 10 executives +31 30 228 92 2; Add an executive. AM-Pharma News . Anything missing? We search for you. Print or download . CEO. …See details»
AM-Pharma 2025 Company Profile: Valuation, Funding …
AM-Pharma General Information Description. Operator of a medical research firm intended to develop alkaline phosphatase biologic therapies to treat acute …See details»
AM Pharma
Sep 10, 2015 AM‐Pharma is a biopharmaceutical company focused on the preclinical and clinical development of recAP (recombinant Human Alkaline Phosphatase) as a treatment of …See details»
AM Pharma Company Profile - Office Locations, Competitors
AM Pharma has 5 employees across 2 locations and $210.28 m in total funding,. See insights on AM Pharma including office locations, competitors, revenue, financials, executives, …See details»
AM-Pharma - Overview, News & Similar companies | ZoomInfo.com
Oct 11, 2023 AM-Pharma Provides Business Update and Outcome of Pre-planned Interim Futility Analysis of Phase 3 REVIVAL Study UTRECHT, The Netherlands--(BUSINESS WIRE) …See details»
AM-Pharma - Profile - dhbriefs.com
AM-Pharma is a clinical-stage biopharmaceutical company developing a treatment for sepsis-associated acute kidney injury (SA-AKI) - recombinant human alkaline phosphatase …See details»
AM-Pharma - F6S
AM-Pharma - AM-Pharma’s purpose is to save and improve the lives of patients confronted with severe medical conditions. Our focus is on cardiac surgery-associated renal damage (CSA …See details»
AM PHARMA Company Profile | Thane, Maharashtra, India
Find company research, competitor information, contact details & financial data for AM PHARMA of Thane, Maharashtra. Get the latest business insights from Dun & Bradstreet.See details»
AM-Pharma - BCF Career
AM-Pharma BV is a biopharmaceutical company developing recombinant Alkaline Phosphatase for clinical use. AM-Pharma’s purpose is to save the lives of patients confronted with kidney …See details»
AM-Pharma BV - Drug pipelines, Patents, Clinical trials - Synapse
Explore AM-Pharma BV with its drug pipeline, therapeutic area, technology platform, 17 clinical trials, 20 news, and 1 literature, Disease Domain:Endocrinology and Metabolic Disease, …See details»
AM-Pharma - Gilde Healthcare
AM-Pharma is a Dutch biopharmaceutical company developing a biotherapeutic for the treatment of Sepsis Associated Acute Kidney Injury (SA-AKI). The company successfully completed a …See details»
☑️AM-Pharma — Consulting Organization from the Netherlands …
AM-Pharma — Consulting Organization from the Netherlands with 11-50 employees, it`s involved in Health, Laboratory & Measurement sectors. Our website uses cookies to enable essential …See details»
About Us - AM Pharma
Martijn Kleijwegt, is a Managing Partner and Founder at LSP and a pioneer in the European life sciences arena. He was instrumental in the successes of Prosensa (NL, IPO in 2013, sold to …See details»
AM-Pharma: Revenue, Worth, Valuation & Competitors 2025
About AM-Pharma. AM-Pharma is a Biotech related company founded in 2002 with 38 employees an estimated revenue of $2.9M, and. It has 10 competitors including Dermavant Sciences, …See details»
AM-Pharma | Biotech Careers
AM–Pharma is a biopharmaceutical company developing proprietary recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to transform the treatment prospects …See details»
AM Pharma - Funding, Financials, Valuation & Investors
AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases. New. Resources. Advanced Search. Start Free Trial . …See details»
Investors - AM Pharma
AM-Pharma is backed by a strong syndicate of international investors, including venture capital funds and corporate venture funds. To date, the company has raised over €190 million in …See details»
Yale Law Journal - Does Pharma Need Patents?
Introduction. Does pharma need patents? The consensus view among scholars is a resounding “yes.” The pharmaceutical industry is widely agreed to be the sector most in need of strong …See details»
Silo Pharma, Inc. Announces Agreement with Frontage ... - Nasdaq
2 days ago Silo Pharma announces agreement for FDA-required safety study of SPC-15, an intranasal PTSD treatment, with Frontage Laboratories. ... May 14, 2025 — 08:51 am EDT.See details»